Papers
Briggs, L. G., M. Kim, A. Gusev, F. Rumpf, A. Feldman, F. McGovern, S. Tabatabaei and D. M. Dahl (2021). "Evaluation of in-office MRI/US fusion transperineal prostate biopsy via free-hand device during routine clinical practice." Urology 155: 26-32.
Islam, M. T., F. Rumpf, Y. Tsuno, S. Kodani, T. Sakurai, A. Matsui, T. Maejima and M. Mieda (2022). "Vasopressin neurons in the paraventricular hypothalamus promote wakefulness via lateral hypothalamic orexin neurons." Current Biology.
Abstracts
Rumpf, F., A. Plym, J. Vaselkiv, M. Preston, A. Kibel, L. Mucci and K. Salari (2022). "MP43-10; IMPACT OF FAMILY HISTORY AND GERMLINE GENETIC RISK VARIANTS ON LONG-TERM OUTCOMES OF ACTIVE SURVEILLANCE-ELIGIBLE PROSTATE CANCER." Journal of Urology 207(Supplement 5): e744.
Cheng, L. L., A. S. Feldman, L. A. Vandergrift, I. H. Muti, F. Rumpf, A. Gusev, Y. Berker, M. R. Cardoso, T. L. Fuss, E. D. Negroponte, S. Wu, F. Ehret, C. A. Dietz, S. S. Dinges, T. Chulroek, E. Nicaise, P. Habbel, M. Ayree, J. Nowak, D. M. Dahl, C.-L. Wu and M. Harisinghani (2022). "Abstract 2222: Detecting clinically significant prostate cancers: Tissue metabolomics refines multiparametric MRI-ultrasound fusion prostate biopsy." Cancer Research 82(12_Supplement): 2222-2222.
Gusev, A., F. Rumpf, K. Salari, J. Twum-Ampofo, M. F. Wszolek, D. M. Dahl, M. L. Blute and A. S. Feldman (2021). "Conditional progression-free survival in men on active surveillance for prostate cancer stratified by NCCN risk." Journal of Clinical Oncology 39(6_suppl): 222-222.
Harvey, J., A. Gusev, F. Rumpf, K. Salari, J. Twum-Ampofo, M. Wszolek, D. Dahl, M. Blute and A. Feldman (2021). "MP62-12; CONDITIONAL FREEDOM FROM PROGRESSION ON ACTIVE SURVEILLANCE OF PROSTATE CANCER STRATIFIED BY NCCN RISK." Journal of Urology 206(Supplement 3): e1096-e1097.
Harvey, J., A. Gusev, J. Twum-Ampofo, A. Pieretti, F. Rumpf, A. Yu, K. Salari, D. Dahl and A. Feldman (2021). "PD17-08; IMPACT OF SERIAL PROSTATE MULTIPARAMETRIC MRI ON TREATMENT FREE SURVIVAL IN MEN ON ACTIVE SURVEILLANCE." Journal of Urology 206(Supplement 3): e287-e288.